Notice of Intent to Award a Sole Source Contract to Hitachi FDA-133701
Summary
AI-generated · Jun 05, 2026FDA intends to award a sole-source, firm-fixed-price commercial purchase order to Hitachi.
The Food and Drug Administration (FDA) intends to award a Sole Source firm-fixed price commercial Purchase Order to Hitachi. (See attached Notice of Intent)
From Special Notice posted on Jun 04, 2026Notice history
1-
Special Notice LATEST Posted Jun 04, 2026
Details
Award Information
Not yet awarded
Contacts
Phone
Agency
Place of Performance
USA